Odense C

• COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffering from chronic pancreatitis Pending
  2025-522956-25-00 5 Chronic pancreatitis
• A study to learn more about how safe BAY 3771249 is and how well it works in people with advanced or metastatic colorectal cancer that has a … Pending
  2025-523648-11-00 3 adenocarcinoma of the colon or rectum
• A clinical trial to learn about the effects of JFI447 and how it shows up in scans compared to FFG233 in people with solid tumors Pending
  2025-523665-24-00 1 Patients with metastatic PDAC, NSCLC, HR+/HER2- ductal and lobular BC,
• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat … Pending
  2025-523735-19-00 5 Metastatic Microsatellite Stable Colorectal Cancer
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• Study of IBI3009 alone or in combination with other therapies for extensive-stage small cell lung cancer Pending
  2025-523972-21-00 7 Extensive-Stage Small Cell Lung Cancer
• Pulmonary Embolism & Anticoagulation Evaluation in Cancer Patient - PEACE Pending
  2025-524110-28-00 6 Incidental Subsegmental Pulmonary Embolism in cancer patients
• Self-Assessment Method for Statin side-effects Or Nocebo 2 Pending
  2025-524955-30-01 11 Cardiovascular diseases
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• SCARFREE-001: Verteporfin for Scar Prevention Pending
  2025-525083-14-00 4 Scar formation following surgical wounds
• RESET C2 Pending
  2026-525214-62-00 4 Localised dMMR Colon Cancer
• A multicentre, adaptive, randomised, multidomain, platform trial for dose optimization in the treatment of adult patients with haematologica … Pending
  2026-525658-13-00 6 Haematological diseases; any disorder that primarily affects the blood
• A clinical trial of MK-1045 in people with B-cell acute lymphoblastic leukemia Recruiting
  2025-522267-15-00 10 2026-06-24 ​Relapsed/refractory B-cell Acute Lymphoblastic Leukemia​
• A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorect … Recruiting
  2025-523521-18-00 5 2026-06-09 Metastatic Colorectal Cancer
• HOVON 178 WM: Treatment of Waldenstrom’s macroglobulinemia with epcoritamab if the disease comes back during or after previous treatment Recruiting
  2025-522295-91-00 9 2026-06-05 relapsed or refractory Waldenstrom’s macroglobulinemia
• Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Recruiting
  2025-521590-13-00 5 2026-05-28 Moderately to Severely Active Crohn’s Disease
• Study of GVV858 as a single agent or in combination with endocrine therapy in patients with HR+/HER2- breast cancer and other advanced solid … Recruiting
  2025-521911-38-00 7 2026-05-26 Advanced HR+/HER- breast cancer
• A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting
  2023-508047-40-00 5 2026-04-30 Ovarian cancer
• A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study) Recruiting
  2025-522125-36-00 3 2026-04-22 Chronic hepatitis D infection
• A study to investigate efficacy, safety, immunogenicity, and pharmacokinetics of GSK3862995B following repeat doses in participants with bro … Recruiting
  2025-522892-27-00 4 2026-03-21 Bronchiectasis
• A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. Recruiting
  2025-522553-19-00 10 2026-02-25 Symptomatic genetic and familial dilated cardiomyopathy.
• A Global Phase III Study of Puxitatug Samrotecan (AZD8205) Monotherapy Compared with Physician’s Choice of Chemotherapy for B7-H4-Selected E … Recruiting
  2024-518777-34-00 5 2026-02-11 B7-H4-Selected Advanced/Metastatic Endometrial Cancer.
• A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific … Recruiting
  2025-522767-15-00 5 2026-01-27 Acute Myeloid Leukemia
• A clinical study of sacituzumab tirumotecan for cervical cancer (MK-2870-036) Recruiting
  2025-521514-26-00 5 2026-01-26 Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W

Showing 25–48 of 467 trials